Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells
Abstract Pulmonary vascular remodeling is a key pathological process of pulmonary arterial hypertension (PAH), characterized by uncontrolled proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs). Bortezomib (BTZ) is the first Food and Drug Administration (FDA)‐approved prote...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-06-01
|
| Serier: | Kaohsiung Journal of Medical Sciences |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/kjm2.12835 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
